Recent news on Valganciclovir

New Data Show Oral Valcyte(R) (valganciclovir) as Effective as iv ...  -  May 9, 2007
campus med,These important data show that oral valganciclovir has clinical equivalence to the current gold-standard treatment, intravenous ganciclovir,

New Data Show Oral Valcyte(R) (valganciclovir) as Effective as iv ...  -  May 9, 2007
Juraforum.de,These important data showthat oral valganciclovir has clinical equivalence to the currentgold-standard treatment, intravenous ganciclovir,

Is this the cure for ME?  -  Apr 15, 2007
Daily Mail,Valganciclovir is licensed to treat HHV-6 infections of the eye, which can affect transplant or cancer patients with severely weakened immune systems.

Generous hearts  -  Apr 4, 2007
The Kingston Whig-Standard,...covers 85 per cent of drug costs, but the Yaworskis will still have to find another $280 a month for an anti-viral medication called Valganciclovir.

Dale Guyer, MD, Discusses the Integrative and Molecular Treatment ...  -  Apr 5, 2007
ProHealth's ImmuneSupport.com,While oral agents such as acyclovir, Famvir R and Valtrex R often have good benefit, the recent utilization of Valcyte R [valganciclovir] has been a

BD Biosciences and Roche Collaborate to Advance the Study of Cell ...  -  Mar 8, 2007
Drug Newswire (press release),Medicines discovered at Roche Palo Alto include CellCept(R) (mycophenolate mofetil), Valcyte(R) (valganciclovir) and Naprosyn(R) (naproxen).

BD Biosciences and Roche Collaborate to Advance the Study of Cell ...  -  Feb 27, 2007
PipelineReview.com (press release),Medicines discovered at Roche Palo Alto include CellCept® (mycophenolate mofetil), Valcyte® (valganciclovir) and Naprosyn® (naproxen).

Sufferers find chronic fatigue syndrome tiring to explain  -  Feb 21, 2007
Chicago Defender,University School of Medicine released a study about the effectiveness of treating chronic fatigue syndrome with the antiviral drug, valganciclovir.

New treatment for chronic fatigue  -  Feb 3, 2007
Bradenton Herald,Montoya uses a drug called valganciclovir that targets the two viruses, which often occur together in chronic fatigue sufferers.

Roche Posts Outstanding Results for 2006  -  Feb 7, 2007
PharmaLive.com (press release),Virology - sales growth driven mainly by Tamiflu Combined sales of Valcyte (valganciclovir) and Cymevene (ganciclovir) continued to show strong growth in

Preliminary study offers hope for Chronic Fatigue Syndrome patients  -  18 Jan 2007
DailyIndia.com,Montoya and Kogelnik emphasized that even if their new clinical trial validates the use of valganciclovir in treating some CFS patients, the drug may not be

Daily Dose: Tips For Tea Drinkers; Trusting Instincts; New ...  -  18 Jan 2007
NBC 10.com,The drug is Valganciclovir, an antiviral used in treating diseases caused by the human herpes virus. Researchers said that of 25 patients treated with the

New therapy for chronic fatigue syndrome to be tested at Stanford  -  Jan 11, 2007
innovations report,Valganciclovir is normally used against diseases caused by viruses in the herpes family, including cytomegalovirus, Epstein-Barr virus and human herpes

Herpes drug may help with chronic fatigue  -  Jan 9, 2007
Earthtimes.org9 A US study suggests valganciclovir, a drug often used in treating diseases caused by human herpes viruses, may help with chronic fatigue syndrome.

A New Therapy for CFS  -  Jan 11, 2007
MedIndia,MD, associate professor of medicine (infectious diseases), and postdoctoral scholar Andreas Kogelnik, MD, PhD, have used the drug valganciclovir - an

New drug could help relieve chronic fatigue syndrome  -  Jan 9, 2007
Stanford Daily,Jose Montoya and postdoctoral student Andreas Kogelnik have seen 21 of the 25 patients they have treated over the past three years with drug valganciclovir

Stanford rolls out new chronic fatigue fix  -  Jan 16, 2007
Palo Alto Daily News,Montoya uses a drug called valganciclovir that targets the two viruses, which often occur together in chronic fatigue sufferers.

Drug to be tested on ME patients  -  Jan 11, 2007
Times Online,...shown symptoms related to the herpes virus were given the drug valganciclovir, an anti-viral drug that is often used to treat herpes-related diseases.

Dr. Hans-Joachim Bohm Named President of Roche Palo Alto  -  Dec 11, 2006
Drug Newswire (press release),Medicines discovered at Roche Palo Alto include CellCept(R) (mycophenolate mofetil), Valcyte(R) (valganciclovir) and Naprosyn(R) (naproxen).

Dr. Hans-Joachim Bohm Named President of Roche Palo Alto  -  Dec 11, 2006
Yahoo! News (press release)Medicines discovered at Roche Palo Alto include CellCept® (mycophenolate mofetil), Valcyte® (valganciclovir) and Naprosyn® (naproxen).

Options for treating ganciclovir-resistant CMV discussed at IDSA ...  Oct 16, 2006
This is of significant concern as CMV can become resistant to the current standard-of-care medications, ganciclovir and valganciclovir, leaving few treatment ... -Aidsmap, Dr. Hans-Joachim Bohm Named President of Roche Palo Alto  -  Dec 11, 2006
Drug Newswire (press release),Medicines discovered at Roche Palo Alto include CellCept(R) (mycophenolate mofetil), Valcyte(R) (valganciclovir) and Naprosyn(R) (naproxen).



Is this the cure for ME?  17 May 2006
...month by Professor Jose Montoya of Stanford University in California, involved 12 patients who had been given the powerful drug valganciclovir, which targets ... - Daily Mail - UK

Roche Sues to Block Approval of Ranbaxy Version of Valcyte  May 3, 2006
...is seeking approval from the US Food and Drug Administration to sell a version of Valcyte, which contains the key ingredient valganciclovir hydrochloride. ... - Bloomberg





Controlling the Troll  Mar 20, 2006
A particularly intriguing regimen to study in high-risk patients would be the combination of valacyclovir prophylaxis and valganciclovir preemptive therapy. - Annals of Internal Medicine

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional